Key Reference Articles

Key References & Reviews of Therapeutics Articles

Key Articles and Guidelines in the Management of Arrhythmias, 2004–2010 (Vol 31, No 1)
Judy W. M. Cheng, Pharm.D., M.P.H., FCCP, Anna Legreid Dopp, Pharm.D., James S. Kalus, Pharm.D., Kelly C. Rogers, Pharm.D., Cynthia A Sanoski, Pharm.D., FCCP, and C. Michael White, Pharm.D., FCP, FCCP
Pharmacologic Prophylaxis of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Beyond b-Blockers (Vol 30, No 7)
Estella M. Davis, Pharm.D., Kathleen A. Packard, Pharm.D., and Daniel E. Hilleman, Pharm.D., FCCP
Appendix 1 to Le J, Dodds-Ashley E, Neuhauser MM, et al. Consensus Summary of Aerolsolized Antimicrobial Agents (Vol 30, No 6)
Key Articles Related to Complementary and Alternative Medicine in Cardiovascular Disease: Part 1 (Vol 30, No 1)
Sheryl L. Chow, Pharm.D., Michael P. Dorsch, Pharm.D., M.S., Steven P. Dunn, Pharm.D., Cynthia A. Jackevicius, Pharm.D., M.Sc., FCSHP, Robert L. Page, II, Pharm.D., M.S.P.H., FCCP, FAHA, FASHP, Toby Trujillo, Pharm.D., Orly Vardeny, Pharm.D., Barbara Wiggins, Pharm.D., FAHA, FCCP, and Barry E. Bleske, Pharm.D., FCCP
Key Articles and Guidelines in the Treatment of Venous Thromboembolism (Vol 29, No 11)
Paul P. Dobesh, Pharm.D., FCCP, Ann K. Wittkowsky, Pharm.D., FASHP, FCCP, Zachary Stacy, Pharm.D., William E. Dager, Pharm.D., FCSHP, Toby C. Trujillo, Pharm.D., Michael P. Gulseth, Pharm.D., Edith Nutescu, Pharm.D., FCCP, and Tom Vondracek, Pharm.D.
Key Articles and Guidelines Relative to Intensive Care Unit Pharmacotherapy: 2009 Update (Vol 29, No 10)
Brian L. Erstad, Pharm.D., FCCM, FCCP, FASHP, Gretchen M. Brophy, Pharm.D., FCCP, FCCM, Steven J. Martin, Pharm.D., FCCP, FCCM, Curtis E. Haas, Pharm.D., FCCP, John W. Devlin, Pharm.D., FCCM, FCCP, Lynda S. Welage, Pharm.D., FCCP, and William E. Dager, Pharm.D., FCSHP, FCCP, FCCM
Key Articles Relative to Cardiovascular Pharmacogenomics (Vol 29, No 9)
Christina L. Aquilante, Pharm.D., Amber L. Beitelshees, Pharm.D., M.P.H., Larisa H. Cavallari, Pharm.D., Craig R. Lee, Pharm.D., Ph.D., Stephanie Maciejewski, Pharm.D., Kathryn M. Momary, Pharm.D., Orly Vardeny, Pharm.D., and Issam Zineh, Pharm.D., M.P.H.
Key Articles and Guidelines for the Prevention of Venous Thromboembolism (Vol 29, No 4)
Paul P. Dobesh, Pharm.D., FCCP, Ann K. Wittkowsky, Pharm.D., FASHP, FCCP, Zachary Stacy, Pharm.D., William E. Dager, Pharm.D., FCSHP, Stuart T. Haines, Pharm.D., FCCP, Larry M. Lopez, Pharm.D., FCCP, Edith Nutescu, Pharm.D., FCCP, Katherine W. Phillips, Pharm.D., Toby C. Trujillo, Pharm.D., and Tom Vondracek, Pharm.D.
High-Impact Articles Related to the Management of Heart Failure: 2008 Update (Vol 29, No 1)
Cynthia A. Jackevicius, Pharm.D., M.Sc., Robert L. Page II, Pharm.D., FCCP, FAHA, Sheryl Chow, Pharm.D., Steven P. Dunn, Pharm.D., Craig R. Lee, Pharm.D., Ph.D., Tien M. H. Ng, Pharm.D., Jo E. Rodgers, Pharm.D., Orly Vardeny, Pharm.D., Barbara S. Wiggins, Pharm.D., and Mark A. Munger, Pharm.D., FCCP
Key Articles and Guidelines in the Management of Hypertension: 2008 Update (Vol 28, No 8)
Sarah M. Gaffney, Pharm.D., Simon de Denus, M.Sc.(Pharm.), Kari L. Olson, Pharm.D., Toni L. Ripley, Pharm.D., Bryan Robinette, Pharm.D., Kelly M. Summers, Pharm.D., and Anne P. Spencer, Pharm.D.
Key Articles and Guidelines in the Management of Acute Coronary Syndromes and in Percutaneous Coronary Intervention: 2007 Update (Vol 27, No 12)
Paul P. Dobesh, Pharm.D., FCCP, Sara D. Brouse, Pharm.D., William E. Dager, Pharm.D., FCSHP, Sarah A. Spinler, Pharm.D., FCCP, Zachary Stacy, Pharm.D., and Barbara S. Wiggins, Pharm.D.
Key Articles, Guidelines, and Consensus Papers Relative to the Treatment of Dyslipidemias -- 2005 (Vol 26, No 7)
Matthew K. Ito, Pharm.D., FCCP, Rebecca J. Cheung, Pharm.D. Eric K. Gupta, Pharm.D., Kimberly K. Birtcher, Pharm.D., Pang H. Chong, Pharm.D., Theresa M. Bianco, Pharm.D., and Barry E. Bleske, Pharm.D., FCCP
Key Articles and Guidelines Relative to Intensive Care Unit Pharmacology--2004 (Vol 25, No 4)
Brian L. Erstad, Pharm.D., FCCM, FCCP, FASHP, Steven J. Martin, Pharm.D., FCCP, FCCM, Gretchen M. Brophy, Pharm.D., FCCP, FCCM, Curtis E. Haas, Pharm.D., FCCP, Judith Jacobi, Pharm.D., FCCM, FCCP, Lynda S. Welage, Pharm.D., FCCP, and Michael C. Thomas, Pharm.D.
Key References in Infectious Diseases Pharmacotherapy (Vol 24, No 11)
Richard H. Drew, Pharm.D., M.S., on Behalf of the American College of Clinical Pharmacy Infectious Diseases Practice and Research Network Bibliography Group
High-Impact Articles Related to the Pharmacotherapeutic Management of Systolic Heart Failure (Vol 24, No 11)
Tien M. H. Ng, Pharm.D., Orly Carter, Pharm.D., Gregory S. Guillory, Pharm.D., Patricia A. Howard, Pharm.D., FCCP, Craig R. Lee, Pharm.D., Jo E. Rodgers, Pharm.D., Patricia A. Uber, Pharm.D., Barbara S. Wiggins, Pharm.D., Mark A. Munger, Pharm.D., FCCP, and J. Herbert Patterson, Pharm.D., FCCP
Key Articles and Guidelines in the Management of Hypertension (Vol 24, No 10)
Simon de Denus, M.Sc.(Pharm.), Angela M. Hardy, Pharm.D., Kari L. Olson, Pharm.D., and Bryan Robinette, Pharm.D.
Key Articles and Guidelines in Pharmacotherapeutic Management of Arrhythmias (Vol 24, No 2)
Judy W. M. Cheng, Pharm.D., Lori Frank, Pharm.D., Stephanie D. Garrett, Pharm.D., Yun Lu, Pharm.D., M.S., Cynthia A. Sanoski, Pharm.D., and C. Michael White, Pharm.D.
Key Articles and Guidelines Relative to Treatment of Patients with Acute Coronary Syndromes (Vol 24, No 1)
Paul P. Dobesh, Pharm.D., Sara D. Brouse, Pharm.D., Daniel C. Johnson, Pharm.D., William E. Dager, Pharm.D., FCSHP, Dawn Bell, Pharm.D., Denise E. Daly, Pharm.D., Jacqueline L. Olin, M.S., Pharm.D., and Anna M. Wodlinger, Pharm.D.